CD44 and neoplasm: The expression of tumor stem cell markers (CD44, CD133, and OCT4) were also notably increased by exosomal miR-4800-3p and miR-4800-3p mimic, respectively (Figures 4E, F), while knockdown of miR-4800-3p decreased these tumor stem cell markers.